ASSOCIATION OF A CYTOSTATIC DRUG (E.39 BAYER) WITH RADIOTHERAPY IN TREATMENT OF MALIGNANCIES

被引：0
|
作者：
DESTREE, F
机构：
来源：
PRESSE MEDICALE | 1961年 / 69卷 / 38期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：1639 / &
相关论文
共 5 条
  • [1] THE TREATMENT OF MALIGNANT TUMOURS WITH CYTOSTATIC AGENTS (E39-BAYER)
    SCHWERMER, B
    SCHREIBER, HW
    DEUTSCHE MEDIZINISCHE WOCHENSCHRIFT, 1958, 83 (09) : 331 - &
  • [2] THE TREATMENT OF MALIGNANT TUMOURS AND LEUKAEMIAS WITH ETHYLENEIMINOQUINONE (E-39 BAYER)
    KLEINFELDER, H
    GEBERT, E
    REISERT, P
    DEUTSCHE MEDIZINISCHE WOCHENSCHRIFT, 1958, 83 (11) : 413 - 422
  • [3] Efficacy of benzydamine hydrochloride, chlorhexidine, and povidone iodine in the treatment of oral mucositis among patients undergoing radiotherapy in head and neck malignancies: A drug trail
    Roopashri, G.
    Jayanthi, K.
    Guruprasad, R.
    CONTEMPORARY CLINICAL DENTISTRY, 2011, 2 (01) : 8 - 12
  • [4] A Phase I study of oral administration of mTOR inhibitor everolimus (E) in association with cisplatin (C) and radiotherapy (R) for the treatment of locally advanced cervix cancer (LACC) - PHOENIX I
    Ferreira, Carlos Gil
    Guerra Alves, Flavia V.
    Grazziotin, Rachele
    Erlich, Felipe
    Moralez, Giulliana
    Carneiro, Michel P.
    Dias, Mariane Fontes
    de Melo, Andreia C.
    CANCER RESEARCH, 2014, 74 (19)
  • [5] A Dose-finding and Biomarker Evaluation Phase Ib Study of Everolimus in Association With 5-Fluorouracil and Pelvic Radiotherapy as Neoadjuvant Treatment of Locally Advanced Rectal Cancer (E-LARC Study)
    Gelsomino, Fabio
    Bertolini, Federica
    Luppi, Gabriele
    Spallanzani, Andrea
    Pettorelli, Elisa
    Bonetti, Luca Reggiani
    Meduri, Bruno
    Manco, Gianrocco
    Conte, Pierfranco
    Cascinu, Stefano
    CLINICAL COLORECTAL CANCER, 2017, 16 (04) : 410 - +
1